Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-10-03
2006-10-03
Helms, Larry (Department: 1643)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S006120, C435S320100
Reexamination Certificate
active
07115727
ABSTRACT:
A novel gene 282P1G3 and its encoded protein, and variants thereof, are described wherein 282P1G3 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 282P1G3 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 282P1G3 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 282P1G3 can be used in active or passive immunization.
REFERENCES:
patent: 6476212 (2002-11-01), Lalgudi et al.
patent: 6576607 (2003-06-01), Schachner
patent: 6682888 (2004-01-01), Loring et al.
patent: 2004/0022790 (2004-02-01), Schachner
patent: 20103510 (2001-06-01), None
patent: 1 394 274 (2004-03-01), None
patent: 1 447 413 (2004-08-01), None
patent: WO-93/16178 (1993-08-01), None
patent: WO-96/32959 (1996-10-01), None
patent: WO-98/45435 (1998-10-01), None
patent: WO-00/58357 (2000-10-01), None
patent: WO-01/55206 (2001-08-01), None
patent: WO-01/55314 (2001-08-01), None
patent: WO-01/57272 (2001-08-01), None
patent: WO-01/57273 (2001-08-01), None
patent: WO-01/57274 (2001-08-01), None
patent: WO-01/57275 (2001-08-01), None
patent: WO-01/57276 (2001-08-01), None
patent: WO-01/57277 (2001-08-01), None
patent: WO-01/57278 (2001-08-01), None
patent: WO-01/66719 (2001-09-01), None
patent: WO-01/75067 (2001-10-01), None
patent: WO-01/86003 (2001-11-01), None
patent: WO-01/92581 (2001-12-01), None
patent: WO-02/10449 (2002-02-01), None
patent: WO-02/18632 (2002-03-01), None
patent: WO-03/016475 (2003-02-01), None
patent: WO-03/068268 (2003-08-01), None
patent: WO-03/080795 (2003-10-01), None
patent: WO-03/087768 (2003-10-01), None
patent: WO-04/016734 (2004-02-01), None
patent: WO-04/023973 (2004-03-01), None
patent: WO-04/028479 (2004-04-01), None
patent: WO-04/048938 (2004-06-01), None
patent: WO-04/066948 (2004-08-01), None
Greenbaum et al., Genome Biology, 2003, vol. 4 (9), pp. 117.1-117.8.
Alberts et al. Molecular Biology of the Cell, 3rd Edition, 1994, p. 465.
Mallampalli et al., Biochem. J. 1996, vol. 38, pp. 333-341.
Fu et al., EMBO journal, 1996, vol. 15, pp. 4392-4402.
Challita-Eid Pia M.
Faris Mary
Ge Wangmao
Jakobovits Aya
Raitano Arthur B.
Agensys, Inc.
Helms Larry
Morrison & Foerster / LLP
Sang Hong
LandOfFree
Nucleic acids and corresponding proteins entitled 282P1G3... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acids and corresponding proteins entitled 282P1G3..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acids and corresponding proteins entitled 282P1G3... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3672365